Medtronic (MDT) Tops Q3 EPS by 3c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT)
February 18, 2025 8:13 AM ESTRaymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).
The analyst comments "F3Q results were mixed, as revenue missed and adj. EPS beat. The primary revenue variance (vs. RJe/consensus) was in Surgical, which... More
